• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT CRM S.R.L. REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT CRM S.R.L. REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number REPLY DR
Device Problem Material Integrity Problem (2978)
Patient Problem Insufficient Information (4580)
Event Date 03/22/2021
Event Type  Injury  
Event Description
Reportedly, the subject pacemaker was implanted on (b)(6) 2011 to treat an avb.The patient was hospitalized from (b)(6) to (b)(6) 2021 to replace the pacemaker and leads, which were not operating correctly.During the previous follow-ups, a dysfunction of the atrial lead was observed (increase of the lead impedance and loss of capture), then a similar issue was observed on the ventricular lead.The ecg performed before the re-intervention was normal (sinus rhythm, with normal pr interval, avb).On (b)(6) 2021, upon explantation of the pacemaker, a complete fracture of the header was observed, explaining the dysfunctioning of the leads.The leads were tested with a psa.Proper operation of the leads was observed with thresholds below 1v.As a result, the leads were kept implanted and connected to a new pacemaker.
 
Manufacturer Narrative
Preliminary of analysis of the returned device showed that its header was detached from the can.
 
Event Description
Reportedly, the subject pacemaker was implanted on (b)(6) 2011 to treat an avb.The patient was hospitalized from (b)(6) 2021 to replace the pacemaker and leads, which were not operating correctly.During the previous follow-ups, a dysfunction of the atrial lead was observed (increase of the lead impedance and loss of capture), then a similar issue was observed on the ventricular lead.The ecg performed before the re-intervention was normal (sinus rhythm, with normal pr interval, avb).On (b)(6) 2021, upon explantation of the pacemaker, a complete fracture of the header was observed, explaining the dysfunctioning of the leads.The leads were tested with a psa.Proper operation of the leads was observed with thresholds below 1v.As a result, the leads were kept implanted and connected to a new pacemaker.It should be noted that the patient suffered a fracture in 2015.Preliminary analysis of the available patient files showed unstable and high ventricular lead impedances (in the order of 3000 ohms) since (at least) (b)(6) 2020.Loss of ventricular capture was observed in the real time test from (b)(6) 2021.Episodes with non-physiological signals were noted in both channels since (at least) (b)(6) 2021.An intermittent behavior was identified relative to the ventricular channel.
 
Manufacturer Narrative
B5 updated.H6 (type of investigation) updated.Review of the device history records showed no anomaly.
 
Event Description
Reportedly, the subject pacemaker was implanted on (b)(6) 2011 to treat an avb.The patient was hospitalized from (b)(6) 2021 to replace the pacemaker and leads, which were not operating correctly.During the previous follow-ups, a dysfunction of the atrial lead was observed (increase of the lead impedance and loss of capture), then a similar issue was observed on the ventricular lead.The ecg performed before the re-intervention was normal (sinus rhythm, with normal pr interval, avb).On (b)(6) 2021, upon explantation of the pacemaker, a complete fracture of the header was observed, explaining the dysfunctioning of the leads.The leads were tested with a psa.Proper operation of the leads was observed with thresholds below 1v.As a result, the leads were kept implanted and connected to a new pacemaker.It should be noted that the patient suffered a fracture in 2015.Preliminary analysis of the available patient files showed unstable and high ventricular lead impedances (in the order of 3000 ohms) since (at least) (b)(6) 2020.Loss of ventricular capture was observed in the real time test from (b)(6) 2021.Episodes with non-physiological signals were noted in both channels since (at least) (b)(6) 2021.An intermittent behavior was identified relative to the ventricular channel.
 
Event Description
Reportedly, the subject pacemaker was implanted on (b)(6) 2011 to treat an avb.The patient was hospitalized from (b)(6) 2021 to replace the pacemaker and leads, which were not operating correctly.During the previous follow-ups, a dysfunction of the atrial lead was observed (increase of the lead impedance and loss of capture), then a similar issue was observed on the ventricular lead.The ecg performed before the re-intervention was normal (sinus rhythm, with normal pr interval, avb).On (b)(6) 2021, upon explantation of the pacemaker, a complete fracture of the header was observed, explaining the dysfunctioning of the leads.The leads were tested with a psa.Proper operation of the leads was observed with thresholds below 1v.As a result, the leads were kept implanted and connected to a new pacemaker.It should be noted that the patient suffered a fracture in the tibia in 2015.Preliminary analysis of the available patient files showed unstable and high ventricular lead impedances (in the order of 3000 ohms) since (at least) (b)(6) 2020.Loss of ventricular capture was observed in the real time test from (b)(6) 2021.Episodes with non-physiological signals were noted in both channels since (at least) (b)(6) 2021.An intermittent behavior was identified relative to the ventricular channel.
 
Manufacturer Narrative
B5 updated.Please refer to the attached analysis report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REPLY
Type of Device
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
MICROPORT CRM S.R.L.
via crescentino s.n.
saluggia (vc), 13040
IT  13040
Manufacturer (Section G)
MICROPORT CRM S.R.L.
via crescentino s.n.
saluggia (vc), 13040
IT   13040
Manufacturer Contact
elodie vincent
via crescentino s.n.
saluggia (vc), 13040
IT   13040
MDR Report Key12525213
MDR Text Key273088251
Report Number1000165971-2021-00654
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P950029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/28/2013
Device Model NumberREPLY DR
Device Catalogue NumberREPLY DR
Device Lot Number2549
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2021
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/31/2021
Initial Date FDA Received09/24/2021
Supplement Dates Manufacturer Received10/19/2021
12/06/2021
01/13/2022
Supplement Dates FDA Received11/12/2021
12/21/2021
01/19/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/28/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-